These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3941763)

  • 1. Dietary treatment of adrenoleukodystrophy.
    Suzuki S; Kobayashi T; Goto I; Kuroiwa Y
    Neurology; 1986 Jan; 36(1):104-6. PubMed ID: 3941763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenoleukodystrophy: dietary oleic acid lowers hexacosanoate levels.
    Rizzo WB; Phillips MW; Dammann AL; Leshner RT; Jennings SS; Avigan J; Proud VK
    Ann Neurol; 1987 Mar; 21(3):232-9. PubMed ID: 3037987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Very long-chain fatty acids in erythrocyte membrane phospholipids in adrenoleukodystrophy.
    Tanaka K; Shimada M; Naruto T; Yamamoto H; Nishizawa K; Saeki Y
    Acta Paediatr Jpn; 1989 Apr; 31(2):136-43. PubMed ID: 2516693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The design of a diet restricted in saturated very long-chain fatty acids: therapeutic application in adrenoleukodystrophy.
    Van Duyn MA; Moser AE; Brown FR; Sacktor N; Liu A; Moser HW
    Am J Clin Nutr; 1984 Aug; 40(2):277-84. PubMed ID: 6465061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new dietary therapy for adrenoleukodystrophy: biochemical and preliminary clinical results in 36 patients.
    Moser AB; Borel J; Odone A; Naidu S; Cornblath D; Sanders DB; Moser HW
    Ann Neurol; 1987 Mar; 21(3):240-9. PubMed ID: 2440378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenoleukodystrophy: abnormality of very long-chain fatty acids in erythrocyte membrane phospholipids.
    Antoku Y; Sakai T; Goto I; Iwashita H; Kuroiwa Y
    Neurology; 1984 Nov; 34(11):1499-1501. PubMed ID: 6493501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenoleukodystrophy: fatty acid analysis of total glycerophospholipids in erythrocyte membranes.
    Antoku Y; Sakai T; Goto I; Katafuchi Y; Sato H; Iwashita H; Kuroiwa Y
    Acta Neurol Scand; 1985 Aug; 72(2):193-7. PubMed ID: 4050328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of saturated and polyunsaturated very-long-chain fatty acids in fibroblasts from patients with defects in peroxisomal beta-oxidation.
    Street JM; Singh H; Poulos A
    Biochem J; 1990 Aug; 269(3):671-7. PubMed ID: 2117919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The adrenoleukodystrophy-adrenomyeloneuropathy complex: is it treatable?
    Kolodny EH
    Ann Neurol; 1987 Mar; 21(3):230-1. PubMed ID: 2440377
    [No Abstract]   [Full Text] [Related]  

  • 10. Visual evoked potentials in adrenoleukodystrophy: a trial with glycerol trioleate and Lorenzo oil.
    Kaplan PW; Tusa RJ; Shankroff J; Heller J; Moser HW
    Ann Neurol; 1993 Aug; 34(2):169-74. PubMed ID: 8338341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic plasma exchange in treatment of adrenoleukodystrophy.
    Bambauer R; Schiel R; Cordes H; Latza R
    Ther Apher; 2000 Oct; 4(5):338-41. PubMed ID: 11111814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary erucic acid therapy for X-linked adrenoleukodystrophy.
    Rizzo WB; Leshner RT; Odone A; Dammann AL; Craft DA; Jensen ME; Jennings SS; Davis S; Jaitly R; Sgro JA
    Neurology; 1989 Nov; 39(11):1415-22. PubMed ID: 2682348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow transplant in adrenoleukodystrophy.
    Moser HW; Tutschka PJ; Brown FR; Moser AE; Yeager AM; Singh I; Mark SA; Kumar AA; McDonnell JM; White CL
    Neurology; 1984 Nov; 34(11):1410-7. PubMed ID: 6387532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hexacosanoic and docosanoic acids plasma levels in patients with cerebral childhood and asymptomatic X-linked adrenoleukodystrophy: Lorenzo's oil effect.
    Deon M; Garcia MP; Sitta A; Barschak AG; Coelho DM; Schimit GO; Pigatto M; Jardim LB; Wajner M; Giugliani R; Vargas CR
    Metab Brain Dis; 2008 Mar; 23(1):43-9. PubMed ID: 18026827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple diagnostic method of adrenoleukodystrophy: total fatty acid analysis of erythrocyte membranes.
    Antoku Y; Sakai T; Tsukamoto K; Imanishi K; Ohtsuka Y; Iwashita H; Goto I
    Clin Chim Acta; 1987 Oct; 169(1):121-5. PubMed ID: 3677434
    [No Abstract]   [Full Text] [Related]  

  • 16. Adrenoleukodystrophy and variants. Clinical, neurophysiological and biochemical studies in patients and family members.
    Goto I; Kobayashi T; Antoku Y; Tobimatsu S; Kuroiwa Y
    J Neurol Sci; 1986 Jan; 72(1):103-12. PubMed ID: 3081689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new therapeutic approach for X-linked adrenoleukodystrophy.
    Cappa M; Bertini E; Di Capua M; Rimoldi M; Uziel G
    Eur J Pediatr; 1990 May; 149(8):595-6. PubMed ID: 2347360
    [No Abstract]   [Full Text] [Related]  

  • 18. Membrane microviscosity is increased in the erythrocytes of patients with adrenoleukodystrophy and adrenomyeloneuropathy.
    Knazek RA; Rizzo WB; Schulman JD; Dave JR
    J Clin Invest; 1983 Jul; 72(1):245-8. PubMed ID: 6874949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotype heterogeneity among hemizygotes in a family biochemically screened for adrenoleukodystrophy.
    Cotrufo R; Melone MA; Monsurro MR; Di Iorio G; Carella C; Moser HW
    Am J Med Genet; 1987 Apr; 26(4):833-8. PubMed ID: 3591825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Familial adrenoleukodystrophy].
    Le Fur JM; Le Meur F; Parent P; Toudic L; Castel Y
    J Genet Hum; 1985 Dec; 33(5):427-34. PubMed ID: 4093772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.